Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6209930 | The Journal of Arthroplasty | 2014 | 4 Pages |
Abstract
A total of 1659 primary THAs using a cemented custom-made intra-operative manufactured prosthesis (IMP)-stem were studied. The end point for survival was defined as revision of the stem for any reason. Revision arthroplasty was performed in 49 cases. The IMP-stems had a revision free 20-year survival rate of 95.5%. Revisions were performed mainly because of aseptic loosening. There were no drawbacks like increased infection risk due to the prolonged surgical time needed for the intra-operative production of the stem. These data provide evidence that the cemented IMP-stem is able to provide good long-term results.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Sascha MD, Alain MD, Anne MD, Michiel MD, PhD,